bioRxiv · 10.1101/2020.12.04.409144
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2
Abstract
Coronavirus disease 2019 (COVID-19) includes the cardiovascular complications in addition to respiratory disease. SARS-CoV-2 infection impairs endothelial function and induces vascular inflammation, leading to endotheliitis. SARS-CoV-2 infection relies on the binding of Spike glycoprotein (S protein) to angiotensin converting enzyme 2 (ACE2) in the host cells. We show here that S protein alone can damage vascular endothelial cells (ECs) in vitro and in vivo, manifested by impaired mitochondrial function, decreased ACE2 expression and eNOS activity, and increased glycolysis. The underlying mechanism involves S protein downregulation of AMPK and upregulation of MDM2, causing ACE2 destabilization. Thus, the S protein-exerted vascular endothelial damage via ACE2 downregulation overrides the decreased virus infectivity.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Lei, Y., Zhang, J., Schiavon, C. R., He, M., Chen, L., Shen, H., Zhang, Y., Yin, Q., Cho, Y., Andrade, L., Shadel, G. S., Hepokoski, M., Lei, T., Wang, H., Yuan, J. X.- J., Malhotra, A., Manor, U., Wang, S., Yuan, Z.-Y., Shyy, J. Y.-J.. 2020-12-04. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2. https://doi.org/10.1101/2020.12.04.409144
Cite the original work for its findings. Save a collection to share your selection of sources.